EUVIMEDObjevte EUVIMED
CrossrefInformační karta

Efficacy of Native T1 Mapping in differentiation between viable and non-viable myocardium in chronic ischemia

Diab Mahmoud S, Gad Azza A.H, Abdel Lattif Reda A, Mahrous Mary R

Journal of Medicine in Scientific Research · 2023-01-01 · 7 (1)

DOI: 10.59299/2537-0928.1059 ↗
AbstraktBibliografické údaje

Abstrakt

Background Myocardial ischemia may lead to reversible or irreversible myocardial insult. A precise assessment of myocardial viability (MV) is of clinical relevance to determine the recovery potential of the affected segments. Contrast enhanced cardiac magnetic resonance (CE-CMR) with late gadolinium (Gd) sequences is the gold standard method for MV assessment. Our study tasted the accuracy of segmental native T1 mapping (NT1M) imaging as a non-contrast technique for assessing MV. Methods: Forty-three patients with chronic myocardial ischemia underwent 1.5 T CMR. Imaging protocol includes cine images to assess left ventricular (LV) function, and (LGE) images to detect and estimate the extension of myocardial enhancement (ME). Segments with > 75% enhancement were considered ischemic non-viable (INV). Segmental NT1M (modified Look-Locker inversion recovery MOLLI sequence 5(3)3) was obtained at basal, mid-ventricular and apical levels. Segmental native T1 mapping values (NT1MV) were analyzed and referred to the LGE results. Results This study included 688 myocardial segments, which were divided into healthy myocardium (HM) (No LGE)= 422 segments, ischemic viable myocardium (IVM) (LGE Conclusions Segmental NT1MV correlate well with the transmural (TM) extent of the myocardial scar, and distinguish between HM, IVM, and INVM.

Znalosti, které odpovídají vaší práci.

Od bezplatného začátku přes osobní rešerše literatury až po kompletní Research Suite.

Zobrazit tarify →

Jsou zahrnuty všechny plné texty vydavatelů?

Ne. Bibliografické záznamy, abstrakty a plné texty jsou různé typy obsahu. To, zda je plný text dostupný, závisí na zdroji, Open Access a vašich stávajících licencích. Tarif EUVIMED nenahrazuje dodatečná vydavatelská práva.

Zobrazit tarify →